Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.
Bhatia V, Kamat NV, Pariva TE, Wu LT, Tsao A, Sasaki K, Sun H, Javier G, Nutt S, Coleman I, Hitchcock L, Zhang A, Rudoy D, Gulati R, Patel RA, Roudier MP, True LD, Srivastava S, Morrissey CM, Haffner MC, Nelson PS, Priceman SJ, Ishihara J, Lee JK.
Bhatia V, et al. Among authors: rudoy d.
Nat Commun. 2023 Apr 11;14(1):2041. doi: 10.1038/s41467-023-37874-2.
Nat Commun. 2023.
PMID: 37041154
Free PMC article.